top of page
​
​
HOME
ABOUT US
EXECUTIVE TEAM
ADVISORY BOARD
BOARD OF DIRECTORS
OUR PLATFORM
INVESTORS
NEWS
CONTACT
IMPRESSUM
Mehr
Use tab to navigate through the menu items.
Pause
News
Ymmunobio & Paul-Scherrer Institute win Innosuisse grant to develop radiopharmaceutical with YB-800
Jan 26
We are very proud to announce our 3rd place achievement at the Prix Galien USA Awards!
Nov 14, 2024
Countdown to the Prix Galien Awards: Showcasing Science-Driven Innovation in NYC!
Oct 31, 2024
READ MORE
Dr. Katrin Rupalla Interviewed by Global Business Reports
Apr 26, 2023
Drug Discovery & Development
Jan 31, 2023
Fierce Biotech: Appointment of Michel Janicot
Jan 13, 2023
SEE MORE NEWS
All Posts
Press Releases
In the News
Scientific Publications
CEACAM1 inhibits Toll-like receptor 2–triggered antibact. responses of pulmonary epithelial cells
Authors: Hortense Slevogt, Solveig Zabel, Bastian Opitz, Andreas Hocke, Julia Eitel, Philippe D N'Guessan, Lothar Lucka, Kristian...
Oct 5, 2008
NEWS
Our science is making news.
Stay in touch.
Follow us on
LinkedIn
.
Join our mailing list
Email
Subscribe
Thanks for subscribing!
bottom of page
